Chi Sheng Pharma & Biotech Co., Ltd (TPEX:4111)

Market Cap	1.71B
Revenue (ttm)	1.17B
Net Income (ttm)	110.63M
Shares Out	56.98M
EPS (ttm)	1.93
PE Ratio	15.57
Forward PE	n/a
Dividend	1.00 (3.34%)
Ex-Dividend Date	Aug 23, 2024

Volume	150,921
Average Volume	270,174
Open	29.80
Previous Close	29.90
Day's Range	29.80 - 30.25
52-Week Range	24.55 - 32.10
Beta	0.15
RSI	43.00
Earnings Date	Mar 14, 2025

About TPEX:4111

Chi Sheng Pharma & Biotech Co., Ltd engages in the manufacturing, processing, sale, and import and export trade of pharmaceuticals, medical products, cosmetics, health foods, and medical equipment in Taiwan and internationally. Its products portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic agents; hormones and adrenal cortical steroids; autonomic nerves agents; antihistamines and antipruritics; antipyretics and analgesi...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1962
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4111

Financial Performance

In 2024, TPEX:4111's revenue was 1.17 billion, an increase of 9.86% compared to the previous year's 1.06 billion. Earnings were 110.63 million, an increase of 61.10%.